改善免疫与监测数据的质量和利用:免疫战略咨询专家组工作组总结报告
工作组将数据质量定义为准确、精确、相关、完整且足够及时以满足预期用途,数据利用定义为数据实际用于免疫规划管理、绩效监测和决策的程度,并指出可持续改善需覆盖治理、人员、工具和流程,且应以国家为主导、从一线向上驱动。
要点
- 数据质量定义为准确、精确、相关、完整且及时适用于预期用途。
- 可持续改善需覆盖卫生系统治理、人员、工具和流程,并采用持续质量改进。
- 国家层面需将数据质量与利用监测嵌入免疫和监测绩效监测中。
核心结论
- 可持续改善免疫与监测数据质量和利用需要卫生系统各层面共同努力,包括治理、人员、工具和流程,并采用持续质量改进方法。
- 相关方法应因地制宜、由国家主导并从一线向上驱动。
主要发现
- 数据质量依赖于卫生机构的高质量数据收集,但许多干预措施针对国家或次国家层面或聚焦新技术,而非功能信息系统所需的人员和有利环境。
- 工作组明确了各规划层级在免疫和监测数据质量与利用方面的角色和责任。
关键数值与推荐
- 数据质量定义为数据准确、精确、相关、完整且足够及时以满足预期用途(fit-for-purpose)。
- 数据利用定义为数据实际用于既定目的(如免疫规划管理、绩效监测、决策)的程度。
临床怎么用
- 国家层面需将数据质量与利用监测与免疫和监测绩效监测并列。
- 从机构层面开始提升数据质量与利用的劳动力能力和水平。
- 改进免疫规划目标(分母)的准确性。
- 加强利用现有数据指导定制化规划行动(如免疫规划规划、管理和政策变化)。
- 采用数据驱动的持续质量改进方法作为卫生系统强化的一部分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Concerns about the quality and use of immunization and vaccine-preventable disease (VPD) surveillance data have been highlighted on the global agenda for over two decades. In August 2017, the Strategic Advisory Group of Experts (SAGE) established a Working Group (WG) onthe Quality and Use of Global Immunization and Surveillance Data to review the current status and evidence to make recommendations, which were presented to SAGE in October 2019. The WG synthesized evidence from landscape analyses, literature reviews, country case-studies, a data triangulation analysis, as well as surveys of experts. Data quality (DQ) was defined as data that are accurate, precise, relevant, complete, and timely enough for the intended purpose (fit-for-purpose), and data use as the degree to which data are actually used for defined purposes, e.g., immunization programme management, performance monitoring, decision-making. The WG outlined roles and responsibilities for immunization and surveillance DQ and use by programme level. The WG found that while DQ is dependent on quality data collection at health facilities, many interventions have targeted national and subnational levels, or have focused on new technologies, rather than the people and enabling environments required for functional information systems. The WG concluded that sustainable improvements in immunization and surveillance DQ and use will require efforts across the health system - governance, people, tools, and processes, including use of data for continuous quality improvement (CQI) - and that the approaches need to be context-specific, country-owned and driven from the frontline up. At the country level, major efforts are needed to: (1) embed monitoring DQ and use alongside monitoring of immunization and surveillance performance, (2) increase workforce capacity and capability for DQ and use, starting at the facility level, (3) improve the accuracy of immunization programme targets (denominators), (4) enhance use of existing data for tailored programme action (e.g., immunization programme planning, management and policy-change), (5) adopt a data-driven CQI approach as part of health system strengthening, (6) strengthen governance around piloting and implementation of new information and communication technology tools, and (7) improve data sharing and knowledge management across areas and organizations for improved transparency and efficiency. Global and regional partners are requested to support countries in adopting relevant recommendations for their setting and to continue strengthening the reporting and monitoring of immunization and VPD surveillance data through processes periodic needs assessment and revision processes. This summary of the WG's findings and recommendations can support "data-guided" implementation of the new Immunization Agenda 2030.
引用
- Scobie HM, Edelstein M, Nicol E, et al. Improving the quality and use of immunization and surveillance data: Summary report of the Working Group of the Strategic Advisory Group of Experts on Immunization. Vaccine. 2020. PMID: 32950304. doi:10.1016/j.vaccine.2020.09.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。